UK and Ireland Fellowship Programme
Welcome
The Gilead UK & Ireland Fellowship Programme started in 2009. The aim of the Programme is to support local innovation and best practice in patient care in HIV, viral hepatitis, oncology/haematology, respiratory and invasive fungal disease. The Programme invites applications from healthcare or allied professionals who are seeking funding for a project that aligns with the goals of the Gilead UK & Ireland Fellowship Programme.
Applicants are required to demonstrate how their project meets the specified criteria in order to be awarded funding. Successful applicants are expected to communicate progress of their project, and to present their findings at the end of the funding period.
Since its inception, the Gilead UK & Ireland Fellowship Programme has supported over 150 projects in the areas of HIV, viral hepatitis, respiratory and invasive fungal disease. Since 2009 this has left an important legacy within the research areas funded. Further details of successful applications can be found here.
To find out more about the programme, register your interest or apply for a grant, visit the Gilead Giving website here.
01
2009
The Gilead UK & Ireland Fellowship Programme was formed in 2009, working in the disease areas of HIV, hepatitis B, invasive fungal disease and respiratory.
02
2010
In 2010 a Best Practice Sharing Event was introduced for HIV and viral hepatitis projects supported by the Gilead UK & Ireland Fellowship Programme. Project leads had the opportunity to attend and share the learnings and successes of their supported projects. Three of these events have taken place to date. Projects funded in Invasive fungal disease are presented at the annual conference of the British Society for Medical Mycology.
03
2013
In 2013 the hepatitis B disease area expanded its criteria to cover grants in hepatitis C, building on the foundation of 4 years of grants in hepatitis B.
04
2014
The Gilead UK & Ireland Fellowship Programme partnered with the Cystic Fibrosis Trust in 2014, by providing an additional grant for its Cystic Fibrosis Fellowship. The grant enabled specialist training in cystic fibrosis medicine, aiming to train the specialist cystic fibrosis centre directors of the future.
05
2015
In 2015, the Gilead UK & Ireland Fellowship Programme introduced oncology as a new disease area for grants support, as well as continuing the Programme in the established disease areas.
06
2016
In 2016, the Gilead UK & Ireland Fellowship Programme accepted applications for HIV, viral hepatitis, IFD and oncology/haematology and awarded grants to 26 projects.
07
2017
In 2017, the Gilead UK & Ireland Fellowship Programme accepted applications for HIV, viral hepatitis, IFD and oncology/haematology and awarded grants to 27 projects.
08
2018
In 2018, the Gilead UK & Ireland Fellowship Programme accepted applications for HIV, viral hepatitis, IFD and oncology/haematology and awarded grants to 18 projects.
